<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05080985</url>
  </required_header>
  <id_info>
    <org_study_id>2018-1608</org_study_id>
    <nct_id>NCT05080985</nct_id>
  </id_info>
  <brief_title>Paravertebral Block Versus Erector Spinae Plane Block for Analgesia in Modified Radical Mastectomy</brief_title>
  <official_title>Paravertebral Block Versus Erector Spinae Plane Block for Analgesia and Opioid Consumption in Modified Radical Mastectomy; Randomized, Prospective, Double Blind</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is planned to be a single-center randomized, prospective double-blind study and&#xD;
      includes patients who planned to be done unilateral MRM (modified radical mastectomy)&#xD;
      operation in Istanbul University Istanbul Faculty of Medicine. The objective of this study is&#xD;
      to compare postoperative analgesic efficacies of TPVB (thoracic paravertebral block) and ESPB&#xD;
      (erector spinae plane block) performed under ultrasound (USG) guidance after MRM. Primary&#xD;
      outcome of this study is postoperative 24-hour morphine consumption whereas secondary&#xD;
      outcomes were planned as the comparison of changes in hemodynamic parameters and numeric&#xD;
      rating pain score (NRS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 86 patients were randomized into TPVB (Group P) and ESPB (Group E) by using closed&#xD;
      envelopes.&#xD;
&#xD;
      All patients in the operating room has same anesthetic management under standard monitoring&#xD;
      modalities. Prior to regional technique, mild sedation was achieved with midazolam (1-2 mg)&#xD;
      and fentanyl (50 mcg). Both blocks were performed under ultrasonography guidance from the&#xD;
      level of T4 vertebra with a linear probe (5MHz; GE Healthcare, Wauwatosa, Wis, USA) using&#xD;
      longitudinally out-of-plane technique by an anesthesiologist. A 22-gauge, 50 mm insulated&#xD;
      stimulating needle was used.By using reference points of C7 and T7, spinous processes of&#xD;
      thoracic vertebras were marked. 10% povidone iodine was used for skin antisepsis. USG probe&#xD;
      was longitudinally placed at the level of T4. Staff anesthesiologist had to visualize of&#xD;
      adjacent muscles, transverse process (TP) and pleura.&#xD;
&#xD;
      For ESPB; confirmation of the needle position was achieved with spread of 2 ml saline between&#xD;
      the deep fascia of the erector spinae muscle and the TP. After negative aspiration 20 ml&#xD;
      0.375% bupivacaine was injected with appropriate distribution of LA.&#xD;
&#xD;
      For TPVB; the needle was advanced passing over superior costotransverse ligament and target&#xD;
      space was confirmed by the downward displacement of pleura after the administration of 2 ml&#xD;
      0.9% NaCl. After negative aspiration, 20 ml 0.375 % bupivacaine was injected with appropriate&#xD;
      distribution of local anesthetics.&#xD;
&#xD;
      Vascular puncture, haematoma, neuraxial injury and pneumothorax were defined as block&#xD;
      complications and should be noted.&#xD;
&#xD;
      30 minutes after the block achieved, pinprick test was performed on both mid-axillary and&#xD;
      midclavicular lines from T1 to T12 (0 there is sensation, 1 decreased sensation, 2 there is&#xD;
      no sensation).&#xD;
&#xD;
      Anesthesia induction was unique for all patients with 0.03 mg kg-1 midazolam, 0.5 mcg kg-1&#xD;
      fentanyl, 2 mg kg-1 propofol and 0.6 mg kg-1 rocuronium. Maintenance was achieved with&#xD;
      sevoflurane of 1 minimum alveolar concentration in a mixture of 40% O2 and 60% N2O. As a&#xD;
      component of multimodal analgesia, paracetamol (1 gr) was applied to all patients before skin&#xD;
      incision.&#xD;
&#xD;
      Hemodynamic data were recorded throughout surgery. An increase more than 20% from baseline in&#xD;
      mean arterial pressure (MAP) was defined as inadequate analgesia and was treated with bolus&#xD;
      fentanyl (50 mcg). Hypotension was described with a decrease more than 20% in MAP and treated&#xD;
      with ephedrine bolus. Bradycardia was determined with a heart rate (HR) less than 50 beats&#xD;
      min-1 and treated with atropine. At the end of surgery, the patients were extubated in&#xD;
      operating room.&#xD;
&#xD;
      Postoperative analgesia was achieved with IV morphine via Patient Controlled Analgesia (PCA)&#xD;
      for 24 hours (0.01 mg kg-1 h-1 basal infusion, 1 mg bolus, 20 minutes lock-out time).&#xD;
&#xD;
      Postoperative follow-up included hemodynamic variables as well as pain scores and morphine&#xD;
      consumption. Adequate analgesia at rest (static) and at moving of the arm interpreted as&#xD;
      45-90 degree abduction (dynamic) was investigated with Numeric Rating Scale (NRS) at 30th&#xD;
      minute and 1st, 4th, 6th, 12th, 24th hours postoperatively. When NRS was 4 and higher,&#xD;
      tramadol should be administered as rescue analgesic. In case of insufficient pain control at&#xD;
      30th minute, dermatomal analgesia should be assessed for both mid-axillary and midclavicular&#xD;
      lines from T1 to T8 by pinprick test (0 there is sensation, 1 decreased sensation, 2 there is&#xD;
      no sensation). Morphine consumption was evaluated at same study times.&#xD;
&#xD;
      Complications were determined as sedation assessed by Ramsey scale, postoperative nausea-&#xD;
      vomiting (PONV) assessed with the four-point categorical scale (0=no PONV, 1=mild nausea,&#xD;
      2=severe nausea or vomiting once, and 3=vomiting more than once). Severe vomiting should be&#xD;
      treated in a multimodal way and excluded from the study (category 2,3).&#xD;
&#xD;
      Staff anesthesiologist responsible for operative course did not contribute in analgesia&#xD;
      assessment, nor in other postoperative follow-up. Other investigators who were blinded to&#xD;
      operative management, collected postoperative data.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 20, 2018</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>amount of postoperative 24 hours morphine consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Static and dynamic pain score assessed with Numeric Rating Scale (NRS).</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>Pain scores will be noted postoperative at 0, 30 minutes and 1,4,6,12,24 hours. NRS=0 (minimum value, no pain). NRS=10 (maximum value, worst pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative heart rate</measure>
    <time_frame>during surgery</time_frame>
    <description>starting from induction to extubation (beat/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative mean arterial pressure</measure>
    <time_frame>during surgery</time_frame>
    <description>starting from induction to extubation (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nause and vomit</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>Assessed with Postoperative Nause and Vomit (PONV) Scale. (0=no PONV, 1=mild nausea, 2=severe nausea or vomiting once, and 3=vomiting more than once)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of blocked dermatome</measure>
    <time_frame>30 minutes after block</time_frame>
    <description>pinprick test in mid-axillar and mid-clavicular line</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group P : TPVB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracic paravertebral block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group E : ESPB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Erector spinae plane block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TPVB</intervention_name>
    <description>20 ml 0.375 % bupivacaine was injected between superior costotransverse ligament and pleura.</description>
    <arm_group_label>Group P : TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESPB</intervention_name>
    <description>20 ml 0.375 % bupivacaine was injected between deep fascia of the erector spinae muscle and transverse process.</description>
    <arm_group_label>Group E : ESPB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacain</intervention_name>
    <description>20 ml 0.375 % bupivacaine was injected</description>
    <arm_group_label>Group E : ESPB</arm_group_label>
    <arm_group_label>Group P : TPVB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  unilateral MRM&#xD;
&#xD;
          -  ages 18-75 years&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) classification I-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of contraindications for using regional anesthesia (not having patient&#xD;
             approval, presence of bleeding-clotting disorders, infection at the injection site,&#xD;
             local anesthetic allergy)&#xD;
&#xD;
          -  chronic analgesic use&#xD;
&#xD;
          -  diabetes mellitus&#xD;
&#xD;
          -  body mass index of (BMI) &gt; 35 kg/m2.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NÃ¼khet Sivrikoz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Attending anesthesiologist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul University, Istanbul Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.</citation>
    <PMID>27501016</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Nukhet Sivrikoz</investigator_full_name>
    <investigator_title>Attending Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Acute postoperative pain</keyword>
  <keyword>Nerve block</keyword>
  <keyword>Thoracic wall</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

